How to buy AmerisourceBergen (ABC) stocks

AmerisourceBergen is a medical distribution business based in the US. AmerisourceBergen shares (ABC) are listed on the NYSE and all prices are listed in US Dollars. AmerisourceBergen employs 46,000 staff and has a trailing 12-month revenue of around $254.4 billion.

Our top picks for where to buy AmerisourceBergen stock

Buy AmerisourceBergen stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

AmerisourceBergen stock price (NYSE: ABC)

Use our graph to track the performance of ABC stocks over time.

AmerisourceBergen stocks at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$0.00 - $0.00
50-day moving average more info button	$181.99
200-day moving average more info button	$172.18
Wall St. target price	$209.57
PE ratio more info button	21.922
Dividend yield more info button	$1.915 (1.08%)
Earnings per share (TTM) more info button	$8.21

Is it a good time to buy AmerisourceBergen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Is AmerisourceBergen stock undervalued or overvalued?

Valuing AmerisourceBergen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AmerisourceBergen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

AmerisourceBergen's P/E ratio

AmerisourceBergen's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, AmerisourceBergen shares trade at around 22x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stock or simply that they're under-valued.

AmerisourceBergen's PEG ratio

AmerisourceBergen's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5767. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into AmerisourceBergen's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

AmerisourceBergen's EBITDA

AmerisourceBergen's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.4 billion.

The EBITDA is a measure of a AmerisourceBergen's overall financial performance and is widely used to measure a its profitability.

AmerisourceBergen financials

Revenue TTM	$254.4 billion
Operating margin TTM	1.01%
Gross profit TTM	$8.3 billion
Return on assets TTM	2.7%
Return on equity TTM	233.66%
Profit margin	0.66%
Book value	$3.39
Market Capitalization more info button	$36.1 billion

TTM: trailing 12 months

AmerisourceBergen stock dividends

Dividend payout ratio: 16.54% of net profits

Recently AmerisourceBergen has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), AmerisourceBergen shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In AmerisourceBergen's case, that would currently equate to about $1.915 per share.

While AmerisourceBergen's payout ratio might seem low, this can signify that AmerisourceBergen is investing more in its future growth.

AmerisourceBergen's most recent dividend payout was on 27 August 2023. The latest dividend was paid out to all shareholders who bought their stocks by 10 May 2023 (the "ex-dividend date").

Have AmerisourceBergen's stocks ever split?

AmerisourceBergen's stocks were split on a 2:1 basis on 15 June 2009 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your AmerisourceBergen stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for AmerisourceBergen stocks, which in turn could have impacted AmerisourceBergen's stock price.

AmerisourceBergen stock price volatility

Over the last 12 months, AmerisourceBergen's stocks have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while AmerisourceBergen's is 0.5622. This would suggest that AmerisourceBergen's stocks are less volatile than average (for this exchange).

AmerisourceBergen overview

AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of AmerisourceBergen is owned by insiders or institutions?
Currently 16.684% of AmerisourceBergen stocks are held by insiders and 78.918% by institutions. How many people work for AmerisourceBergen?
Latest data suggests 46,000 work at AmerisourceBergen. When does the fiscal year end for AmerisourceBergen?
AmerisourceBergen's fiscal year ends in September. Where is AmerisourceBergen based?
AmerisourceBergen's address is: 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 What is AmerisourceBergen's ISIN number?
AmerisourceBergen's international securities identification number is: US03073E1055 What is AmerisourceBergen's CUSIP number?
AmerisourceBergen's Committee on Uniform Securities Identification Procedures number is: 03071P102

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.